asiaticoside has been researched along with Encapsulating Peritoneal Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, H; Dai, H; Huang, L; Shan, Y; Sheng, L; Sheng, M; Sun, J; Tang, L; Wang, F; Yu, M; Zhao, J | 1 |
| Liu, L; Shan, Y; Sheng, M; Shi, J; Yu, M; Zhao, J; Zhu, X; Zhu, Y | 1 |
2 other study(ies) available for asiaticoside and Encapsulating Peritoneal Sclerosis
| Article | Year |
|---|---|
TMT quantitative proteomics and network pharmacology reveal the mechanism by which asiaticoside regulates the JAK2/STAT3 signaling pathway to inhibit peritoneal fibrosis.
Topics: Animals; Cell Line; Epithelial-Mesenchymal Transition; Mice; Molecular Docking Simulation; Network Pharmacology; Peritoneal Fibrosis; Proteomics; Signal Transduction; Transforming Growth Factor beta1 | 2023 |
Asiaticoside inhibits TGF-β1-induced mesothelial-mesenchymal transition and oxidative stress via the Nrf2/HO-1 signaling pathway in the human peritoneal mesothelial cell line HMrSV5.
Topics: Apoptosis; Cell Line; Epithelial Cells; Epithelial-Mesenchymal Transition; Heme Oxygenase-1; Humans; NF-E2-Related Factor 2; Oxidative Stress; Peritoneal Fibrosis; Reactive Oxygen Species; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; Triterpenes | 2020 |